308 related articles for article (PubMed ID: 20021666)
21. Review of deutetrabenazine: a novel treatment for chorea associated with Huntington's disease.
Dean M; Sung VW
Drug Des Devel Ther; 2018; 12():313-319. PubMed ID: 29497277
[TBL] [Abstract][Full Text] [Related]
22. Physician perceptions of pharmacologic treatment options for chorea associated with Huntington disease in the United States.
Sung VW; Iyer RG; Gandhi SK; Shah-Manek B; DiBonaventura M; Abler V; Claassen DO
Curr Med Res Opin; 2018 Apr; 34(4):643-648. PubMed ID: 29383957
[TBL] [Abstract][Full Text] [Related]
23. An experimental model for Huntington's chorea?
Zeef DH; Jahanshahi A; Vlamings R; Casaca-Carreira J; Santegoeds RG; Janssen ML; Oosterloo M; Temel Y
Behav Brain Res; 2014 Apr; 262():31-4. PubMed ID: 24412685
[TBL] [Abstract][Full Text] [Related]
24. Safety of Deutetrabenazine for the Treatment of Tardive Dyskinesia and Chorea Associated with Huntington Disease.
Frank S; Anderson KE; Fernandez HH; Hauser RA; Claassen DO; Stamler D; Factor SA; Jimenez-Shahed J; Barkay H; Wilhelm A; Alexander JK; Chaijale N; Barash S; Savola JM; Gordon MF; Chen M
Neurol Ther; 2024 Jun; 13(3):655-675. PubMed ID: 38557959
[TBL] [Abstract][Full Text] [Related]
25. Tetrabenazine augmentation in treatment-resistant schizophrenia: a 12-week, double-blind, placebo-controlled trial.
Remington G; Kapur S; Foussias G; Agid O; Mann S; Borlido C; Richards S; Javaid N
J Clin Psychopharmacol; 2012 Feb; 32(1):95-9. PubMed ID: 22198452
[TBL] [Abstract][Full Text] [Related]
26. Deutetrabenazine for the treatment of Huntington's chorea.
Bashir H; Jankovic J
Expert Rev Neurother; 2018 Aug; 18(8):625-631. PubMed ID: 29996061
[TBL] [Abstract][Full Text] [Related]
27. [Huntington disease: tetrabenazine compared to haloperidol in the reduction of involuntary movements].
Giménez-Roldán S; Mateo D
Neurologia; 1989 Oct; 4(8):282-7. PubMed ID: 2534679
[TBL] [Abstract][Full Text] [Related]
28. Tetrabenazine in treatment of hyperkinetic movement disorders: an observational study.
Miguel R; Mendonça MD; Barbosa R; Ladeira F; Lampreia T; Vale J; Bugalho P
Ther Adv Neurol Disord; 2017 Feb; 10(2):81-90. PubMed ID: 28382107
[TBL] [Abstract][Full Text] [Related]
29. Tetrabenazine for tardive tremor in elderly adults: a prospective follow-up study.
Kertesz DP; Swartz MV; Tadger S; Plopski I; Barak Y
Clin Neuropharmacol; 2015; 38(1):23-5. PubMed ID: 25580924
[TBL] [Abstract][Full Text] [Related]
30. Long-term tolerability of tetrabenazine in the treatment of hyperkinetic movement disorders.
Kenney C; Hunter C; Jankovic J
Mov Disord; 2007 Jan; 22(2):193-7. PubMed ID: 17133512
[TBL] [Abstract][Full Text] [Related]
31. Deutetrabenazine for Treatment of Chorea in Huntington Disease.
Geschwind MD; Paras N
JAMA; 2016 Jul; 316(1):33-5. PubMed ID: 27380339
[No Abstract] [Full Text] [Related]
32. Depressed mood and suicidality in individuals exposed to tetrabenazine in a large Huntington disease observational study.
Dorsey ER; Brocht AF; Nichols PE; Darwin KC; Anderson KE; Beck CA; Singh S; Biglan KM; Shoulson I
J Huntingtons Dis; 2013; 2(4):509-15. PubMed ID: 25062735
[TBL] [Abstract][Full Text] [Related]
33. Safety and Efficacy of Tetrabenazine and Use of Concomitant Medications During Long-Term, Open-Label Treatment of Chorea Associated with Huntington's and Other Diseases.
Shen V; Clarence-Smith K; Hunter C; Jankovic J
Tremor Other Hyperkinet Mov (N Y); 2013; 3():. PubMed ID: 24255799
[TBL] [Abstract][Full Text] [Related]
34. Long-Term Safety and Tolerability of Valbenazine (NBI-98854) in Subjects with Tardive Dyskinesia and a Diagnosis of Schizophrenia or Mood Disorder.
Josiassen RC; Kane JM; Liang GS; Burke J; O'Brien CF
Psychopharmacol Bull; 2017 Aug; 47(3):61-68. PubMed ID: 28839341
[TBL] [Abstract][Full Text] [Related]
35. Tetrabenazine.
Fasano A; Bentivoglio AR
Expert Opin Pharmacother; 2009 Dec; 10(17):2883-96. PubMed ID: 19929707
[TBL] [Abstract][Full Text] [Related]
36. Tetrabenazine treatment in movement disorders.
Paleacu D; Giladi N; Moore O; Stern A; Honigman S; Badarny S
Clin Neuropharmacol; 2004; 27(5):230-3. PubMed ID: 15602104
[TBL] [Abstract][Full Text] [Related]
37. Tetrabenazine.
Hayden MR; Leavitt BR; Yasothan U; Kirkpatrick P
Nat Rev Drug Discov; 2009 Jan; 8(1):17-8. PubMed ID: 19116624
[No Abstract] [Full Text] [Related]
38. Management of Huntington's disease: role of tetrabenazine.
de Tommaso M; Serpino C; Sciruicchio V
Ther Clin Risk Manag; 2011; 7():123-9. PubMed ID: 21479143
[TBL] [Abstract][Full Text] [Related]
39. Treatment of the symptoms of Huntington's disease: preliminary results comparing aripiprazole and tetrabenazine.
Brusa L; Orlacchio A; Moschella V; Iani C; Bernardi G; Mercuri NB
Mov Disord; 2009 Jan; 24(1):126-9. PubMed ID: 19170197
[TBL] [Abstract][Full Text] [Related]
40. Deutetrabenazine in the treatment of Huntington's disease.
Richard A; Frank S
Neurodegener Dis Manag; 2019 Feb; 9(1):31-37. PubMed ID: 30624137
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
